Welcome to Santa Cruz Biotechnology!

SMA Antibodies

Santa Cruz Biotechnology, Inc. offers a broad range of SMA antibodies. Select SMA antibodies from several monoclonal and/or polyclonal SMA antibodies listed below. View detailed SMA antibody specifications by linking to the specific product blocks. Select appropriate SMA antibodies for your research by isotype, epitope, applications and species reactivity. SMA gene silencer products in siRNA, shRNA Plasmid, shRNA Lentiviral Particle, CRISPR/Cas9 Knockout and CRISPR Double Nickase Plasmid formats are also available as well as CRISPR/dCas9 Activation Plasmids and CRISPR Lenti Activation Systems for gene activation.

Introducing HOVERcruz™,

a unique system for rapid identification of SMA Antibodies. Hover over the icon next to the product names in the table to see representative data for that product.

Live chat is now available! (click here)

Our live chat system is available to answer your product and ordering questions.

PRODUCT NAMECAT. #ISOTYPEEPITOPEAPPLICATIONSSPECIESCITATIONSRATING
SMA5 (D-18)
sc-324317goat IgGC-terminal (h)WB, IF, ELISAhuman2

SMA siRNA, shRNA Plasmid and shRNA Lentiviral Particles gene silencers include:

PRODUCT NAMECAT. #SPECIESAPPLICATIONSMARKERCITATIONS
SMA5 siRNA (h)
sc-92040humanGene SilencingN/A
SMA5 shRNA Plasmid (h)
sc-92040-SHhumanGene SilencingPuromycin
SMA5 shRNA (h) Lentiviral Particles
sc-92040-VhumanGene SilencingPuromycin

SMA5 is a 140 amino acid protein that is encoded by a gene mapping to human chromosome 5, which contains 181 million base pairs and comprises nearly 6% of the human genome. Chromosome 5 is associated with Cockayne syndrome through the ERCC8 gene and familial adenomatous polyposis through the adenomatous polyposis coli (APC) tumor suppressor gene. Treacher Collins syndrome is also chromosome 5-associated and is caused by insertions or deletions within the TCOF1 gene. Deletion of the p arm of chromosome 5 leads to Cri du chat syndrome, while deletion of the q arm or of chromosome 5 altogether is common in therapy-related acute myelogenous leukemias and myelodysplastic syndrome.